A Discussion: Partners and Programs
Since its inception in 1991, CNDR has augmented research and education on AD, PD, LBD, FTLD, ALS, PLS, MND and related disorders in several ways.
First, CNDR fosters collaborative interactions between basic and clinical scientists from Centers, Institutes, Schools and Departments throughout Penn. Secondly, CNDR enhances the development of multidisciplinary research on neurodegenerative disorders by providing core support and collaboration to investigators through CNDR grants from the National Institutes of Health (NIH), foundations, philanthropies and other agencies or commercial entities, and by increasing awareness of neurodegenerative disorders for the public as well as scientists through CNDR sponsored conferences/symposia.
Penn Alzheimer's Disease Center
The Penn Alzheimer's Disease Core Center (ADCC) is one of 32 National Institute on Aging (NIA)-funded Alzheimer's Disease Centers and the only one in the Delaware Valley. Researchers at the ADCs work to translate research advances into improve care and diagnosis for people with AD while at the same time searching for a way to prevent and/or cure AD.
CNDR is home to the Administrative and Neuropathology Cores of the Penn ADCC. CNDR provides leadership, education, and core support to enhance and stimulate investigations into the causes, mechanisms, diagnosis, treatment, and prevention of neurodegenerative diseases. Working with CNDR, the Penn ADCC has contributed to a dramatic expansion in basic and clinical research on AD and related disorders at Penn. Commensurate with this growth, Penn is now recognized as an international leader in research on AD and related disorders.
The ADCC also funds pilot grants in partnership with the Institute on Aging and the Institute of Medicine and Engineering. To connect with the Penn ADCC website, click here.
Alzheimer's Disease Neuroimaging Initiative
The Alzheimer's Disease Neuroimaging Initiative (ADNI) is a 5-year public-private partnership to study whether serial magnetic resonance imaging (MRI), positron emission tomography (PET), other biological markers, and clinical and neuropsychological assessment can be used in combination to measure the progression of mild cognitive impairment and early Alzheimer's disease. Learn more about the program by clicking on this link.
Institute on Aging
The Institute on Aging (IOA) is the oldest aging-focused organization at Penn, founded 30 years ago by the highly regarded geronotologist and researcher, Dr. Vincent Cristofalo, and currently directed by Dr. John Trojanowski. The Institute oversees highly collaborative research, education, and clinical programs. Explore more about the IOA by clicking here to visit its website.
Marian S. Ware Alzheimer Program
The Marian S. Ware Alzheimer Program was established at Penn in 2004, through a gift from the Ware family, with a three-part mission: develop novel therapeutics, conduct clinical research, and advance patient care for AD patients. The Ware Family renewed its financial support of the program in 2009. For more about the Ware Program, click here.
Penn Alzheimer's Disease Core Center and Penn Memory Center
The Penn Memory Center is where individuals and families can come for evaluation and treatment of symptoms of age-related memory loss and participate in ongoing research to learn more about the mechanisms behind memory loss.
To connect with the Penn Memory Center website, click here.
Division of Geriatric Medicine and the PennMARCH Center
The Division of Geriatric Medicine is dedicated to enhancing the health and well-being of older adults through patient care, training of geriatricians, research, and community-based education and demonstration projects. The PennMARCH (Minority Aging Research for Community Health) Center is a research-based and mentoring investment to improve the health and well being of older minority populations by identifying mechanisms for closing the health disparities gap between minority and non-minority elderly populations.
Section of Geriatric Psychiatry
The Geriatric Psychiatry Section’s mission is to improve the mental health and well-being of older adults through innovative translational neuroscience and health care services research, through the education and training of clinicians and future leaders in the field of geriatric mental health, and through direct patient care. Late life is a time of transitions, with increased vulnerability to losses and illnesses that can lead to problems in memory and other cognitive abilities, emotion, and behavior. Our goals are to identify the nature and causes of these common problems, to use the most advanced treatments to help restore mental health, and to discover strategies to enhance resilience against the distinctive stressors of late life.
For more information about the services available through the Section of Geriatric Psychiatry, click here.
Morris K. Udall Parkinson's Disease Research Center of Excellence
The Morris K. Udall Parkinson's Disease Research Center of Excellence - also known as the Penn Udall Center for Parkinson's Research - conducts multidisciplinary research to better understand and develop new treatments for Parkinson's disease (PD), and to educate the public and professional healthcare community about all aspects of PD.
Find out more about the Penn Udall Center, current studies recruiting patients, clinical services, and educational seminars by clicking here.
Penn Frontotemporal Degeneration Center
The Penn Frontotemporal Degeneration Center bridges the gap between research, clinical care, and education. The Center seeks to develop a better understanding of Frontotemporal Dementia (FTD), leading to improved diagnostic testing and the development of treatment trials for FTD.
Find out more about the Frontotemporal Degeneration Center , clinical services, ongoing research, and other information by clicking here.
For more information about the NIA's research initiatives for AD and related dementias, click to read an overview prepared by Dr. John Trojanowski.